Nutex Health Inc. (NASDAQ:NUTX) Shareholders Set to Receive $2.00 Special Dividend

Nutex Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Nutex Health declared a $2.00-per-share special dividend for shareholders of record November 30, payable December 14; the ex-dividend date is November 30.
  • The company reported quarterly EPS of $5.71, topping the $5.54 analyst estimate, while revenue of $217.61 million also exceeded expectations of $214.82 million.
  • MarketBeat previews top five stocks to own in December.

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) declared a special dividend on Tuesday, November 17th. Stockholders of record on Monday, November 30th will be given a dividend of $2.00 per share on Monday, December 14th. The ex-dividend date is Monday, November 30th.

Nutex Health Stock Up 2.8%

NASDAQ:NUTX traded up $4.81 on Tuesday, hitting $174.51. 175,126 shares of the company's stock were exchanged, compared to its average volume of 165,851. The firm has a 50-day moving average price of $201.83 and a 200-day moving average price of $152.17. The company has a debt-to-equity ratio of 0.59, a current ratio of 4.76 and a quick ratio of 4.96. Nutex Health has a 52 week low of $83.99 and a 52 week high of $226.16. The company has a market cap of $1.20 billion, a P/E ratio of 7.45 and a beta of 0.66.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its earnings results on Thursday, November 5th. The company reported $5.71 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.54 by $0.17. Nutex Health had a net margin of 20.68% and a return on equity of 34.43%. The company had revenue of $217.61 million for the quarter, compared to analysts' expectations of $214.82 million. As a group, analysts expect that Nutex Health will post 27.70 EPS for the current fiscal year.

Insider Activity at Nutex Health

In other news, Director Scott Saunders sold 203 shares of the company's stock in a transaction on Friday, September 18th. The shares were sold at an average price of $214.25, for a total value of $43,492.75. Following the sale, the director directly owned 400 shares of the company's stock, valued at approximately $85,700. This represents a 33.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 44.68% of the stock is currently owned by corporate insiders.

Institutional Trading of Nutex Health

Large investors have recently made changes to their positions in the company. BlackRock Inc. purchased a new stake in shares of Nutex Health during the 2nd quarter valued at about $69,612,000. Winmill & CO. Inc. bought a new stake in shares of Nutex Health in the second quarter worth approximately $11,168,000. Empowered Funds LLC bought a new stake in shares of Nutex Health in the second quarter worth approximately $7,720,000. Bank of New York Mellon Corp purchased a new position in shares of Nutex Health during the second quarter valued at approximately $3,956,000. Finally, Bridge City Capital LLC purchased a new position in shares of Nutex Health during the third quarter valued at approximately $3,918,000. 5.32% of the stock is currently owned by institutional investors and hedge funds.

Nutex Health Company Profile

(Get Free Report)

Nutex Health is a Houston-based healthcare company with two main divisions: a Hospital Division and a Management Services Organization (MSO). Its Hospital Division develops and operates micro-hospitals that provide emergency care and other hospital and outpatient services. Through its MSO, Nutex provides administrative, technology, analytics and other management support to affiliated physician-led organizations. These services support care coordination and population health management. Founded by physician Thomas Vo, who serves as the company's chairman and chief executive officer, Nutex operates in the United States.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines